Literature DB >> 31191871

Design, synthesis, and antimicrobial evaluation of 1,4-dihydroindeno[1,2-c]pyrazole tethered carbohydrazide hybrids: exploring their in silico ADMET, ergosterol inhibition and ROS inducing potential.

Mohd Adil Shareef1,2, K Sirisha2,3, Irfan Khan2,3, Ibrahim Bin Sayeed2,3, Surender Singh Jadav1, Gopathi Ramu1,2, C Ganesh Kumar3, Ahmed Kamal4, Bathini Nagendra Babu1,2.   

Abstract

A series of new 1,4-dihydroindeno[1,2-c]pyrazole tethered carbohydrazide hybrids (5a-u) were designed, synthesized and evaluated for their antimicrobial activity. Compounds 5d, 5g, 5j, 5k and 5q demonstrated significant activity against the entire panel of test pathogens. Further, compounds 5d and 5g exhibited significant anti-Candida activity. These potential hybrids (5d and 5g) also exhibited promising ergosterol biosynthesis inhibition against Candida albicans, which was further validated through molecular docking studies. Furthermore, compounds 5d and 5g caused intracellular ROS accumulation in C. albicans MTCC 3017 and were non-toxic to normal human lung cell line MRC5. In silico studies revealed that they demonstrated drug likeness and an appreciable pharmacokinetic profile. Overall, the findings demonstrate that 5d and 5g may be considered as promising leads for further development of new antifungal drugs.

Entities:  

Year:  2019        PMID: 31191871      PMCID: PMC6540956          DOI: 10.1039/c9md00155g

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  35 in total

Review 1.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

Authors:  C A Lipinski; F Lombardo; B W Dominy; P J Feeney
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

2.  Binding of diclofenac sodium with bovine serum albumin at different temperatures, pH and ionic strengths.

Authors:  S K Dutta; S K Basu; K K Sen
Journal:  Indian J Exp Biol       Date:  2006-02       Impact factor: 0.818

3.  New small-size peptides possessing antifungal activity.

Authors:  Francisco M Garibotto; Adriana D Garro; Marcelo F Masman; Ana M Rodríguez; Paul G M Luiten; Marcela Raimondi; Susana A Zacchino; Csaba Somlai; Botond Penke; Ricardo D Enriz
Journal:  Bioorg Med Chem       Date:  2009-11-10       Impact factor: 3.641

Review 4.  The biology and chemistry of antifungal agents: a review.

Authors:  Muthu K Kathiravan; Amol B Salake; Aparna S Chothe; Prashik B Dudhe; Rahul P Watode; Maheshwar S Mukta; Sandeep Gadhwe
Journal:  Bioorg Med Chem       Date:  2012-05-09       Impact factor: 3.641

5.  Prevalence of Cryptococcus neoformans var. neoformans (Serotype D) and Cryptococcus neoformans var. grubii (Serotype A) isolates in New York City.

Authors:  J N Steenbergen; A Casadevall
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

6.  Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations.

Authors:  Stuart K Pitman; Richard H Drew; John R Perfect
Journal:  Expert Opin Emerg Drugs       Date:  2011-08-17       Impact factor: 4.191

Review 7.  Biofilms and catheter-associated urinary tract infections.

Authors:  Sanjay Saint; Carol E Chenoweth
Journal:  Infect Dis Clin North Am       Date:  2003-06       Impact factor: 5.982

8.  Synthesis and antimicrobial potential of nitrofuran-triazole congeners.

Authors:  Ahmed Kamal; S M Ali Hussaini; M Lakshmi Sucharitha; Y Poornachandra; Faria Sultana; C Ganesh Kumar
Journal:  Org Biomol Chem       Date:  2015-08-04       Impact factor: 3.876

9.  Structure-Functional Characterization of Cytochrome P450 Sterol 14α-Demethylase (CYP51B) from Aspergillus fumigatus and Molecular Basis for the Development of Antifungal Drugs.

Authors:  Tatiana Y Hargrove; Zdzislaw Wawrzak; David C Lamb; F Peter Guengerich; Galina I Lepesheva
Journal:  J Biol Chem       Date:  2015-08-12       Impact factor: 5.157

10.  SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules.

Authors:  Antoine Daina; Olivier Michielin; Vincent Zoete
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

View more
  1 in total

1.  Synthesis, Type II diabetes inhibitory activity, antimicrobial evaluation and docking studies of indeno[1,2-c]pyrazol-4(1H)-ones.

Authors:  Satbir Mor; Suchita Sindhu
Journal:  Med Chem Res       Date:  2019-10-26       Impact factor: 1.965

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.